Analysts at HC Wainwright upped their FY2024 earnings estimates for Inovio Pharmaceuticals in a research report issued on ...

This was the stock's fourth consecutive day of losses.

The stock market is where investors connect to buy and sell investments — most commonly, stocks, which are shares of ownership in a public company. Many, or all, of the products featured on this ...

INOVIO (NASDAQ: INO) revealed its strategic milestones for 2025, positioning the company for significant advancements as it ...

H.C. Wainwright lowered the firm’s price target on Inovio (INO) to $3 from $5 and keeps a Neutral rating on the shares after the company ...

Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report)‘s stock had its “market outperform” rating restated by JMP Securities ...

Inovio Pharmaceuticals Inc (INO) stock saw a decline, ending the day at $2.09 which represents a decrease of $-0.19 or -8.33% from the prior close of $2.28. The stock opened at $2.36 and touched a low ...

M&A watch - Flowco Holdings ( FLOC) is expected to start trading after pricing its IPO. The firm provides production ...

JMP Securities analyst Roy Buchanan reiterated a Buy rating on Inovio Pharmaceuticals (INO – Research Report) today and set a price target of ...

TSX:INO.UN) Inovalis Real Estate Investment Trust Announces the Conditional Sale of 87.5% of the Arcueil Property for €37.5 Million ...

Inovalis REIT sells 87.5% of Arcueil property for €37.5 million, expects net proceeds of €6.2 million for capital expenditures and debt reduction.